FTC Seeks to Block Sanofi's Acquisition of Rare Disease Drug That Threatens Sanofi's Monopoly
December 12, 2023
December 12, 2023
WASHINGTON, Dec. 12 -- The Federal Trade Commission issued the following news release on Dec. 11, 2023:
* * *
Deal with Maze Therapeutics would eliminate a nascent competitor to Sanofi in Pompe disease drugs, threatening to stall innovation and deprive patients of lower drug prices
* * *
The Federal Trade Commission is seeking to block Sanofi's proposed acquisition of an exclusive license to Maze Therapeutics Inc.'s therapy in develop . . .
* * *
Deal with Maze Therapeutics would eliminate a nascent competitor to Sanofi in Pompe disease drugs, threatening to stall innovation and deprive patients of lower drug prices
* * *
The Federal Trade Commission is seeking to block Sanofi's proposed acquisition of an exclusive license to Maze Therapeutics Inc.'s therapy in develop . . .